Function of monoamine neurotransmitter transporters
by
Sasa M.
Department of Pharmacology,
Hiroshima University School of Medicine.
Nippon Rinsho 2001 Aug;59(8):1457-64


ABSTRACT

Monoamine transporters include plasma membrane and vesicular monoamine transporters(VMAT). The former selectively and Na+/Cl(-)-dependently transport dopamine, noradrenaline and serotonin into the cytoplasma, and the latter non-selectively carries monoamine into the vesicle. These transporters are composed of amino acid groups containing 12 folds more transmembrane components. Cytoplasmic transporters are a target site of certain drugs. Antiepileptic drugs such as SSRIs and tricyclic antidepressants bind with the serotonin transporter(SERT), noradrenaline transporter(NET) and/or dopamine transporters(DAT) to inhibit transport of monoamines into the cytoplasma, thereby increasing monoamine levels within the synaptic cleft. However, amphetamine, known to induce drug dependence, is transported by DAT and inhibits VMAT to induce reverse-transport of monoamines into the synaptic area, thereby producing psychiatric and behavioral alterations. Thus, monoamine transporters are target sites of drugs, and functional changes in the transporters may be involved in the pathogenesis of affective diseases, schizophrenia and/or personality disorders including neurogenerative diseases such as Parkinson's disease.
Ice
AD/HD
History
Serotonin
Dopamine
Noradrenaline
VTA/glutamate
Self-medication
Worms on speed
Striatal dopamine
The dual deficit model
Dopamine reverse transport
Zinc ions and reverse transport



Refs
and further reading

amphetamines.com
HOME
HedWeb
Nootropics
erythroxylum-coca.com
Cannabis.net
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhappiness?
Utopian Surgery?
The Good Drug Guide
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World